SHL Pharma takes a greener approach

Published: 4-Jul-2011
Packaging Drug Delivery Finance Pharmaceutical

Will provide final assembly, labelling and packaging of drug delivery devices


SHL Group, a privately owned developer of drug delivery systems, has established SHL Pharma to provide final assembly, labelling and packaging services of drug delivery devices such as autoinjectors for the pharmaceutical and biotechnology industries.

The addition of SHL Pharma, which includes a 45,000ft2 facility in South Florida, US with 30,000ft2 of manufacturing space and customised cleanrooms, will enable SHL to take projects from design to distribution. To ensure the automation equipment in-house can accommodate specific assembly needs, SHL Automation has built many of the machines.

The SHL Pharma plant follows Leadership in Energy and Environmental Design (LEED) guidelines and aims to minimise environmental impact by optimising energy performance; using alternative transportation; reducing water usage; managing waste; and using renewable materials.

With construction and renovations completed in April, SHL Pharma is in the process of obtaining ISO 13485 certification, and will be registering with the US FDA as a Drug Establishment, qualified to handle and distribute pharmaceutical products. Additionally, it will conform to all other regulatory requirements for medical device and pharmaceutical packaging and distribution, as per 21 CFR Parts 820, 210 and 211.

  • Companies:
  • SHL Group
See more

You may also like

Drug Delivery

SHL to expand Taiwan production facilities in US$40m investment

Read more
To meet growing demand in the biologic injectable market

Trending Articles

  1. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
  2. Dual-chamber packaging systems as a simplification factor in the supply chain Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
  3. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Drug Delivery

SHL to expand Taiwan production facilities in US$40m investment

To meet growing demand in the biologic injectable market
Drug Delivery

SHL develops drug delivery system for lyophilised drugs

SDI-MIX NIT requires three simple operating steps
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Designing drug devices

Extensive project management expertise and logistical control knowhow are required when working on a combination product from concept to launch. The biopharmaceutical company must select a suitable primary container, filling supplier, regulatory consultants, human factors engineering [HFE] experts and final assembly integrators. Of all the choices that need to be made, selecting the right drug delivery device partner should be considered one of the highest priorities.
You need to be a subscriber to read this article.
Click here to find out more.
Drug Delivery

Autoinjector development

The autoinjector is one of the fastest emerging drug delivery solutions. It consists of a pre-filled syringe or cartridge inside a device that applies enough force to inject fully the desired drug within the specified requirements. Insufficient planning and early conceptual design vulnerabilities can result in quality issues, prolonged project timeline and increased cost. A device manufacturing partner will therefore need basic mechanical device knowledge and regulatory experience.
Packaging

Dual-chamber packaging systems as a simplification factor in the supply chain

Dual-chamber packaging solutions could represent a new frontier also to package parenteral drugs, simplifying the supply chain through reconstitution, potentially making logistics more flexible and efficient, says Cecilia Bassi, Product Manager at Bormioli Pharma
Manufacturing

Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority

The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
Subscribe now